Digisitan – EIT Health Catapult 2023-2024 semi-finalist

Delighted to have been selected by EIT Health as a semi-finalist. Wonderful to be recognised for our groundbreaking work in advancing breast cancer biomarker analytics.

Supported by:

royal society logo
NIHR logo
cancer research uk logo
BIVDA logo

Subscribe to leading news and insights

To stay updated about Digistain’s developments, enter your details opposite. We promise only to send you important news.